• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病的合并症。

Comorbidity in inflammatory bowel disease.

机构信息

Gastroenterology Ramón y Cajal Hospital, E28034 Madrid, Spain.

出版信息

World J Gastroenterol. 2011 Jun 14;17(22):2723-33. doi: 10.3748/wjg.v17.i22.2723.

DOI:10.3748/wjg.v17.i22.2723
PMID:21734780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3122260/
Abstract

Patients with inflammatory bowel disease (IBD) can be affected by other unrelated diseases. These are called comorbid conditions, and can include any secondary health problem that affects a person suffering from a primary or main disease, and which is neither linked physiopathologically to the primary condition, nor is it due to the treatments used for the primary condition or to its long-term anatomical or physiological consequences. Different comorbid conditions, as well as their influence on IBD, are discussed.

摘要

炎症性肠病(IBD)患者可能会受到其他无关疾病的影响。这些被称为合并症,可包括影响患有原发性或主要疾病的人的任何继发性健康问题,且既与原发性疾病在病理生理学上无关联,也不是由于原发性疾病的治疗或其长期的解剖或生理后果所致。本文讨论了不同的合并症及其对 IBD 的影响。

相似文献

1
Comorbidity in inflammatory bowel disease.炎症性肠病的合并症。
World J Gastroenterol. 2011 Jun 14;17(22):2723-33. doi: 10.3748/wjg.v17.i22.2723.
2
Psoriasis and comorbid diseases: Epidemiology.银屑病及其合并症:流行病学
J Am Acad Dermatol. 2017 Mar;76(3):377-390. doi: 10.1016/j.jaad.2016.07.064.
3
Recognizing and managing comorbidities in psoriatic arthritis.银屑病关节炎中共病的识别与管理。
Curr Opin Rheumatol. 2015 Mar;27(2):118-26. doi: 10.1097/BOR.0000000000000152.
4
Gut feelings 2. Mind, mood and gut in inflammatory bowel disease: approaches to psychiatric care.直觉2. 炎症性肠病中的心理、情绪与肠道:精神科护理方法
Australas Psychiatry. 2015 Aug;23(4):407-10. doi: 10.1177/1039856215590034. Epub 2015 Jun 30.
5
Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.肥胖、肠系膜脂肪组织和脂肪因子在炎症性肠病中的作用。
Biomolecules. 2019 Nov 26;9(12):780. doi: 10.3390/biom9120780.
6
Psoriasis and comorbid diseases: Implications for management.银屑病及其合并症:对治疗的启示。
J Am Acad Dermatol. 2017 Mar;76(3):393-403. doi: 10.1016/j.jaad.2016.07.065.
7
What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?在土耳其患者中,原发性硬化性胆管炎与性别及炎症性肠病之间有何关联?
Hepatogastroenterology. 1998 Nov-Dec;45(24):2064-72.
8
Extraintestinal manifestations and complications in IBD.炎症性肠病的肠外表现和并发症。
Nat Rev Gastroenterol Hepatol. 2013 Oct;10(10):585-95. doi: 10.1038/nrgastro.2013.117. Epub 2013 Jul 9.
9
Interaction of obesity and inflammatory bowel disease.肥胖与炎症性肠病的相互作用。
World J Gastroenterol. 2016 Sep 21;22(35):7868-81. doi: 10.3748/wjg.v22.i35.7868.
10
The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study.炎症性肠病中其他慢性炎症性疾病的聚集性:一项基于人群的研究。
Gastroenterology. 2005 Sep;129(3):827-36. doi: 10.1053/j.gastro.2005.06.021.

引用本文的文献

1
Resting functional magnetic resonance images of the brain in functional gastrointestinal diseases: a concise review of the literature.功能性胃肠病患者大脑静息态功能磁共振成像:文献综述
Gastroenterol Hepatol Bed Bench. 2025;18(2):164-176. doi: 10.22037/ghfbb.v18i2.2987.
2
Unravelling the Link Between Hidradenitis Suppurativa and Inflammatory Bowel Disease: A Literature Review.揭开化脓性汗腺炎与炎症性肠病之间的联系:一项文献综述
Biomedicines. 2025 Jul 27;13(8):1833. doi: 10.3390/biomedicines13081833.
3
Circulating miRNA Profile in Inflammatory Bowel Disease Patients with Stress, Anxiety, and Depression.伴有应激、焦虑和抑郁的炎症性肠病患者的循环miRNA谱
Int J Mol Sci. 2025 Jul 29;26(15):7321. doi: 10.3390/ijms26157321.
4
Machine learning prediction of premature death from multimorbidity among people with inflammatory bowel disease: a population-based retrospective cohort study.炎症性肠病患者多种疾病导致过早死亡的机器学习预测:一项基于人群的回顾性队列研究。
CMAJ. 2025 Mar 24;197(11):E286-E297. doi: 10.1503/cmaj.241117.
5
Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorption.克罗恩病中肠道药物代谢酶和转运体的变异性及其对口服药物吸收的潜在影响。
Br J Clin Pharmacol. 2025 Jul;91(7):2028-2044. doi: 10.1002/bcp.70019. Epub 2025 Mar 4.
6
Enhancing patient representation learning with inferred family pedigrees improves disease risk prediction.利用推断的家族谱系增强患者表征学习可改善疾病风险预测。
J Am Med Inform Assoc. 2025 Mar 1;32(3):435-446. doi: 10.1093/jamia/ocae297.
7
A Cross-Sectional Evaluation of Disability in Inflammatory Bowel Disease Using IBD Disk in a Tertiary Center from Romania.在罗马尼亚一家三级中心使用IBD Disk对炎症性肠病患者残疾情况的横断面评估
J Clin Med. 2024 Nov 26;13(23):7168. doi: 10.3390/jcm13237168.
8
From Multimorbidity to Network Medicine in Patients with Rheumatic Diseases.从风湿性疾病患者的多重疾病到网络医学
Rheumatol Ther. 2025 Feb;12(1):1-24. doi: 10.1007/s40744-024-00724-8. Epub 2024 Nov 27.
9
Socioeconomic equality in initiation of biologic treatment in Danish patients with inflammatory bowel disease.丹麦炎症性肠病患者生物治疗起始阶段的社会经济平等性
Wien Klin Wochenschr. 2024 May 24. doi: 10.1007/s00508-024-02376-8.
10
Colonic Dysregulation of Major Metabolic Pathways in Experimental Ulcerative Colitis.实验性溃疡性结肠炎中主要代谢途径的结肠调节异常
Metabolites. 2024 Mar 29;14(4):194. doi: 10.3390/metabo14040194.

本文引用的文献

1
Arterial Stiffness and Wave Reflection: Biomarkers of Cardiovascular Risk.动脉僵硬度与波反射:心血管风险的生物标志物。
Artery Res. 2009 Jun 1;3(2):56-64. doi: 10.1016/j.artres.2009.02.002.
2
Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.炎症性肠病活动期和缓解期的静脉血栓栓塞症:一项队列研究。
Lancet. 2010 Feb 20;375(9715):657-63. doi: 10.1016/S0140-6736(09)61963-2. Epub 2010 Feb 8.
3
A brief report of the epidemiology of obesity in the inflammatory bowel disease population of Tayside, Scotland.苏格兰泰赛德地区炎症性肠病患者肥胖症的流行病学简述报告。
Obes Facts. 2009;2(6):370-2. doi: 10.1159/000262276. Epub 2009 Dec 17.
4
Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis.肾移植后避免或停用类固醇会增加急性排斥反应的风险,但会降低心血管风险。一项荟萃分析。
Transplantation. 2010 Jan 15;89(1):1-14. doi: 10.1097/TP.0b013e3181c518cc.
5
Arterial and venous thromboembolic events during anti-TNF therapy: a study of 85 spontaneous reports in the period 2000-2006.抗 TNF 治疗期间的动脉和静脉血栓栓塞事件:对 2000 - 2006 年期间 85 份自发报告的研究
Biomed Mater Eng. 2009;19(4-5):355-64. doi: 10.3233/BME-2009-0600.
6
C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study.弗雷明汉心脏研究中C反应蛋白与心血管风险重新分类
Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):92-7. doi: 10.1161/CIRCOUTCOMES.108.831198. Epub 2008 Nov 9.
7
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.C-反应蛋白浓度与冠心病、卒中和死亡风险的关系:一项个体参与者荟萃分析。
Lancet. 2010 Jan 9;375(9709):132-40. doi: 10.1016/S0140-6736(09)61717-7. Epub 2009 Dec 22.
8
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.甲氨蝶呤对类风湿关节炎患者心血管疾病的影响:系统文献综述。
Rheumatology (Oxford). 2010 Feb;49(2):295-307. doi: 10.1093/rheumatology/kep366. Epub 2009 Nov 27.
9
Hepatobiliary associations with inflammatory bowel disease.肝胆疾病与炎症性肠病的关系。
Expert Rev Gastroenterol Hepatol. 2009 Dec;3(6):681-91. doi: 10.1586/egh.09.53.
10
Updates in the treatment of gallstones.胆囊结石治疗的新进展。
Expert Rev Gastroenterol Hepatol. 2009 Dec;3(6):649-60. doi: 10.1586/egh.09.57.